Filters
Catalog peptides
Synthesis of unnatural amino acids and other blocks

Gastric Inhibitory Polypeptide (1-30) (porcine)

Name
Gastric Inhibitory Polypeptide (1-30) (porcine)
Molecular structural formula
Purity
≥95%
CAS Number
134875-67-5
Formula
C162H244N40O48S
MW
3552.1
Target
Insulin Receptor
Sequence
Tyr-Ala-Glu-Gly-Thr-Phe-Ile-Ser-Asp-Tyr-Ser-Ile-Ala-Met-Asp-Lys-Ile-Arg-Gln-Gln-Asp-Phe-Val-Asn-Trp-Leu-Leu-Ala-Gln-Lys
Sequence Shortening
YAEGTFISDYSIAMDKIRQQDFVNWLLAQK
References
[1]. Krarup T, et al. Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus. Metabolism. 1987 Jul;36(7):677-82. [2]. G W Morrow, et al. The insulinotropic region of gastric inhibitory polypeptide; fragment analysis suggests the bioactive site lies between residues 19 and 30. Canadian Journal of Physiology and Pharmacology. January 1996. Volume 74.
* All products on our website are for scientific research and cannot be used in human body
Product details
Data download

Gastric Inhibitory Polypeptide (1-30), porcine lacks the C-terminal 12 amino acid residues of natural gastric inhibitory polypeptide (GIP), exhibits biologic activity by potentiating the release of insulin and somatostatin.